CBTRUS统计报告:2012-2016年美国原发性脑及其他中枢神经系统肿瘤诊断
美国中央脑肿瘤登记处(CBTRUS)与美国疾病控制与预防中心和国立癌症研究所合作,基于全美人群数据报告2012-2016年原发性脑及其他中枢神经系统肿瘤的发病与生存情况。所有恶性肿瘤和非恶性肿瘤的平均年年龄调整发病率为23.41/10万,其中恶性为7.08/10万,非恶性为16.33/10万。恶性脑及其他中枢神经系统肿瘤的五年相对生存率为35.8%,非恶性为91.5%。
要点
- 所有恶性与非恶性脑及其他中枢神经系统肿瘤的平均年年龄调整发病率为23.41/10万。
- 恶性中最常见为胶质母细胞瘤(占全部肿瘤14.6%),非恶性中最常见为脑膜瘤(占37.6%)。
- 恶性脑及其他中枢神经系统肿瘤的五年相对生存率为35.8%,非恶性为91.5%。
核心结论
- 本报告提供了美国原发性脑及其他中枢神经系统肿瘤的最新人群数据,所有恶性肿瘤和非恶性肿瘤的平均年年龄调整发病率为23.41/10万。
研究设计与样本
- 美国中央脑肿瘤登记处(CBTRUS)与美国疾病控制与预防中心和国立癌症研究所合作,基于覆盖全美人群的登记数据进行分析。
- 所有率均按2000年美国标准人口进行年龄调整,并以每10万人口表示。
- 儿童和青少年(0-19岁)原发性脑及其他中枢神经系统肿瘤的发病率为6.06/10万。
主要发现
- 所有恶性肿瘤和非恶性肿瘤的平均年年龄调整发病率为23.41/10万,其中恶性为7.08/10万,非恶性为16.33/10万。
- 女性发病率高于男性(25.84 vs 20.82),白人高于黑人(23.50 vs 23.34),非西班牙裔高于西班牙裔(23.84 vs 21.28)。
- 恶性中最常见为胶质母细胞瘤(占全部肿瘤14.6%),非恶性中最常见为脑膜瘤(占全部肿瘤37.6%)。
- 胶质母细胞瘤在男性中更常见,脑膜瘤在女性中更常见。
- 2012年至2016年间,恶性脑及其他中枢神经系统肿瘤死亡数为79,718例,平均年死亡率为4.42/10万。
关键数值与推荐
- 2019年美国预计新诊断恶性与非恶性脑及其他中枢神经系统肿瘤86,010例(恶性25,510例,非恶性60,490例)。
- 恶性脑及其他中枢神经系统肿瘤的五年相对生存率为35.8%。
- 非恶性脑及其他中枢神经系统肿瘤的五年相对生存率为91.5%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors available and supersedes all previous reports in terms of completeness and accuracy. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. The average annual age-adjusted incidence rate (AAAIR) of all malignant and non-malignant brain and other CNS tumors was 23.41 (Malignant AAAIR = 7.08, non-Malignant AAAIR = 16.33). This rate was higher in females compared to males (25.84 versus 20.82), Whites compared to Blacks (23.50 versus 23.34), and non-Hispanics compared to Hispanics (23.84 versus 21.28). The most commonly occurring malignant brain and other CNS tumor was glioblastoma (14.6% of all tumors), and the most common non-malignant tumor was meningioma (37.6% of all tumors). Glioblastoma was more common in males, and meningioma was more common in females. In children and adolescents (age 0-19 years), the incidence rate of all primary brain and other CNS tumors was 6.06. An estimated 86,010 new cases of malignant and non-malignant brain and other CNS tumors are expected to be diagnosed in the US in 2019 (25,510 malignant and 60,490 non-malignant). There were 79,718 deaths attributed to malignant brain and other CNS tumors between 2012 and 2016. This represents an average annual mortality rate of 4.42. The five-year relative survival rate following diagnosis of a malignant brain and other CNS tumor was 35.8%, and the five-year relative survival rate following diagnosis of a non-malignant brain and other CNS tumors was 91.5%.
引用
- Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019. PMID: 31675094. doi:10.1093/neuonc/noz150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。